A new Rab6 homolog cDNA, Rab6c, was discovered by a hypermethylated DNA fra
gment probe that was isolated from a human multidrug resistant (MDR) breast
cancer cell line, MCF7/AdrR, by the methylation sensitive-representational
difference analysis (MS-RDA) technique. Rab6c was found to be under-expres
sed in MCF7/AdrR and MES-SA/Dx5 (a human MDR uterine sarcoma cell line) com
pared with their non-MDR parental cell lines. MCF7/AdrR cells expressing th
e exogenous Rab6c exhibited less resistance to several anti-cancer drugs, s
uch as doxorubicin (DOX), taxol, vinblastine, and vincristine, than the con
trol cells containing the empty vector. Flow cytometry experiments confirme
d that the transfectants' diminished resistance to DOX was caused by increa
sed drug accumulation induced by the exogenous Rab6c. These results indicat
e that Rab6c is involved in drug resistance in MCF7/AdrR cells. (C) 2000 El
sevier Science B.V. All rights reserved.